|
Tello-Montoliu A, Ruiz-Nodar JM, Esteve-Pastor MA, Veliz-Martinez A, Orenes-Pinero E, Macias-Villanego MJ, Lozano T, Carrillo-Aleman L, Vicente-Ibarra N, Pernias-Escrig V, Martinez-Martinez JG, Rivera-Caravaca JM, Marin F. Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year. J Clin Pharmacol. 2019 Feb;59(2):295-302. doi: 10.1002/jcph.1318. Epub 2018 Sep 12. PubMed PMID: 30207603.
AÑO: 2019; IF: 2.425
|
30207603
|
Vicente-Ibarra N, Marin F, Pernias-Escrig V, Sandin-Rollan M, Nunez-Martinez L, Lozano T, Macias-Villaniego MJ, Carrillo-Aleman L, Candela-Sanchez E, Guzman E, Esteve-Pastor MA, Orenes-Pinero E, Valdes M, Rivera-Caravaca JM, Ruiz-Nodar JM. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. Eur J Intern Med. 2019 Mar;61:48-53. doi: 10.1016/j.ejim.2018.12.004. Epub 2018 Dec 20. PubMed PMID: 30579651.
AÑO: 2019; IF: 4.329
|
|
Lorente V, Ariza-Sole A, Jacob J, Formiga F, Marin F, Martinez-Selles M, Viana-Tejedor A, Bardaji A, Sionis A, Palau-Vendrell A, Diez-Villanueva P, Aboal J, Gonzalez-Salvado V, Bueno H. Criteria for admitting elderly patients with acute coronary syndrome to critical care units from Spanish hospital emergency departments: a LONGEVO-SCA cohort study. Emergencias. 2019 Jun;31(3):154-160. English, Spanish. PubMed PMID: 31210446.
AÑO: 2019; IF: 3.173
|
|
Sanchis J., Soler M., Núñez J., Ruiz V., Bonanad C., Formiga F., Valero E., Martínez-Sellés M., Marín F., Ruescas A., García-Blas S., Miñana G., Abu-Assi E., Bueno H., Ariza-Solé A. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome. European Journal of Internal Medicine. April 2019. 62:48-53. 10.1016/j.ejim.2019.01.018
AÑO: 2019; IF: 4.329
|
|
Rios SJ, Rivera-Caravaca JM, Aroca-Valverde C, Reguilon-Gallego L, Castillo-Rodriguez M, Esteve-Pastor MA, Vicente V, Marin F, Roldan V. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists. QJM. 2019 Mar 1;112(3):183-188. doi: 10.1093/qjmed/hcy250. PubMed PMID: 30380132.
AÑO: 2019; IF: 2.529
|